JP2014198723A5 - - Google Patents

Download PDF

Info

Publication number
JP2014198723A5
JP2014198723A5 JP2014136302A JP2014136302A JP2014198723A5 JP 2014198723 A5 JP2014198723 A5 JP 2014198723A5 JP 2014136302 A JP2014136302 A JP 2014136302A JP 2014136302 A JP2014136302 A JP 2014136302A JP 2014198723 A5 JP2014198723 A5 JP 2014198723A5
Authority
JP
Japan
Prior art keywords
prophylactic
therapeutic agent
agent according
indeno
furan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014136302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014198723A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014136302A priority Critical patent/JP2014198723A/ja
Priority claimed from JP2014136302A external-priority patent/JP2014198723A/ja
Publication of JP2014198723A publication Critical patent/JP2014198723A/ja
Publication of JP2014198723A5 publication Critical patent/JP2014198723A5/ja
Pending legal-status Critical Current

Links

JP2014136302A 2011-01-17 2014-07-01 口腔内分散性製剤 Pending JP2014198723A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014136302A JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011007371 2011-01-17
JP2011007371 2011-01-17
JP2011227333 2011-10-14
JP2011227333 2011-10-14
JP2014136302A JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012535507A Division JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016006663A Division JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Publications (2)

Publication Number Publication Date
JP2014198723A JP2014198723A (ja) 2014-10-23
JP2014198723A5 true JP2014198723A5 (enExample) 2015-02-26

Family

ID=45567081

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012535507A Expired - Fee Related JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤
JP2014136302A Pending JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤
JP2016006663A Pending JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012535507A Expired - Fee Related JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016006663A Pending JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Country Status (24)

Country Link
US (6) US20120282191A1 (enExample)
EP (1) EP2665465A1 (enExample)
JP (3) JP5600747B2 (enExample)
KR (1) KR20140014134A (enExample)
CN (1) CN103429223A (enExample)
AR (1) AR084865A1 (enExample)
AU (1) AU2012207818B2 (enExample)
BR (1) BR112013017600A2 (enExample)
CA (1) CA2824430A1 (enExample)
CL (1) CL2013002033A1 (enExample)
CO (1) CO6791611A2 (enExample)
CR (1) CR20130380A (enExample)
EA (1) EA201391053A1 (enExample)
EC (1) ECSP13012825A (enExample)
IL (1) IL227357A0 (enExample)
MA (1) MA34908B1 (enExample)
MX (1) MX2013008314A (enExample)
PE (1) PE20140255A1 (enExample)
PH (1) PH12013501512A1 (enExample)
SG (1) SG191964A1 (enExample)
TW (1) TW201309347A (enExample)
UY (1) UY33869A (enExample)
WO (1) WO2012099260A1 (enExample)
ZA (1) ZA201305567B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
HK1222796A1 (zh) * 2013-07-31 2017-07-14 因特根克斯公司 不含表面活性剂或多元醇的即时可湿性口服薄膜剂型
CA2888219C (en) * 2014-02-07 2018-07-10 Scilabs Pharmaceuticals, Inc. All natural, non-toxic sublingual drug delivery systems
CN105853379A (zh) * 2016-03-31 2016-08-17 北京万全德众医药生物技术有限公司 一种雷美替胺分散片及其制备工艺
CN106389361A (zh) * 2016-03-31 2017-02-15 北京万全德众医药生物技术有限公司 一种含有雷美替胺的口腔崩解片及其制备方法
JP7576905B2 (ja) 2016-05-06 2024-11-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー バレリアン組成物及び関連方法
CN106038502A (zh) * 2016-07-01 2016-10-26 北京万全德众医药生物技术有限公司 一种雷美替胺口崩片及其制备方法
US20210113456A1 (en) * 2017-07-13 2021-04-22 Maxinase Life Sciences Limited Pharmaceutical compositions of ramelteon and methods of use thereof
FI3787596T3 (fi) 2018-05-02 2025-09-29 Ferring Bv Parannettuja farmaseuttisia formulaatioita
JP7552146B2 (ja) * 2019-08-28 2024-09-18 小野薬品工業株式会社 イバブラジンを含有する錠剤
CN113243444A (zh) * 2020-02-13 2021-08-13 罗盖特公司 作为口香糖中的填充剂的多孔淀粉
JP7611556B2 (ja) * 2020-05-28 2025-01-10 日医工株式会社 服用性、安定性等に優れた医薬組成物
CN115778925A (zh) * 2022-12-26 2023-03-14 湖北广济医药科技有限公司 一种雷美替胺口溶膜剂及其制备方法
CN116421582B (zh) 2023-04-03 2026-06-16 杭州成邦医药科技有限公司 一种雷美替胺舌下膜剂及其制备方法
CN120899694A (zh) * 2024-12-20 2025-11-07 上海安必生制药技术有限公司 一种含雷美替胺的药物组合物和鼻腔给药制剂

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
PT914818E (pt) 1996-06-14 2005-08-31 Kyowa Hakko Kogyo Kk Comprimido de desintegracao rapida por via intraoral
JP3460538B2 (ja) 1997-10-08 2003-10-27 救急薬品工業株式会社 速溶性フィルム製剤
PT1121103E (pt) * 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
CN1186098C (zh) 1999-02-15 2005-01-26 住友制药株式会社 在口腔中迅速崩解的片剂
WO2001015735A1 (fr) * 1999-08-26 2001-03-08 Takeda Chemical Industries, Ltd. Matrice adherant a la muqueuse nasale
AU2001248751A1 (en) 2000-04-12 2001-10-23 Banyu Pharmaceutical Co. Ltd. Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
US7008642B1 (en) * 2001-02-12 2006-03-07 Advanced Cardiovascular Systems, Inc. Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
WO2003028706A1 (fr) * 2001-09-28 2003-04-10 Sanwa Kagaku Kenkyusho Co.,Ltd Double comprime a desintegration rapide
FR2834890B1 (fr) 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US20050137247A1 (en) * 2003-12-22 2005-06-23 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of hypertension
CA2602267A1 (en) * 2005-04-04 2006-10-12 Takeda Pharmaceutical Company Limited Use of ramelteon to treat and prevent depression and anxiety disorders
WO2007010173A1 (en) * 2005-07-18 2007-01-25 Colin Lawrence Amess Electrostatic air filter
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
FR2894475B1 (fr) 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
CA2634232C (en) * 2005-12-28 2013-08-20 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
EP2029136A4 (en) * 2006-05-22 2010-01-06 Vanda Pharmaceuticals Inc TREATMENT FOR DEPRESSION DISEASES
US7797869B2 (en) * 2006-07-10 2010-09-21 Tollis David R Multi-section display and utility stanchion
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
KR20090119993A (ko) * 2007-03-13 2009-11-23 다이닛본 스미토모 세이야꾸 가부시끼가이샤 구강내 붕괴정
US20100119601A1 (en) * 2007-04-11 2010-05-13 Pharmaceutical Productions Inc. Melatonin tablet and methods of preparation and use
US20090105490A1 (en) * 2007-07-12 2009-04-23 Nurit Perlman Polymorphic forms of ramelteon and processes for preparation thereof
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
JP2009136240A (ja) 2007-12-10 2009-06-25 Lion Corp チューインガム組成物
US20110130428A1 (en) 2008-06-11 2011-06-02 Astrazeneca Ab Sublingual Compositions Comprising (2S) - (4E) -N-Methyl-5- (3- (5-Isopropoxypyridin) YL)-4-Penten-2-Amine
US7833819B2 (en) * 2008-07-23 2010-11-16 Aptina Imaging Corporation Method and apparatus for decreasing storage node parasitic charge in active pixel image sensors
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
JP2011007371A (ja) 2009-06-23 2011-01-13 Sanyo Electric Co Ltd 空気調和機
JP5513936B2 (ja) * 2010-03-10 2014-06-04 全星薬品工業株式会社 口腔内崩壊製剤
JP5523913B2 (ja) 2010-04-21 2014-06-18 スタンレー電気株式会社 光源装置および照明装置

Similar Documents

Publication Publication Date Title
AU2011221889B2 (en) Film preparation containing medicament with unpleasant taste
FI3936130T3 (fi) Valbenatsiinin annostusohjelma hyperkineettisten liikehäiriöiden hoitoon
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
JP2018021046A5 (enExample)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2017506624A5 (enExample)
JP2014001235A5 (enExample)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2014221827A5 (enExample)
AR084865A1 (es) Preparacion de desintegracion rapida, comprimido dispersable por via oral
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
HRP20250615T1 (hr) Tradipitant za upotrebu u liječenju gastropareze
JP2016530291A5 (enExample)
ME02474B (me) Terapijski režimi
JP2013536837A5 (enExample)
JP2021503483A5 (enExample)
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
FI3600276T3 (fi) Betahistiini tai sen farmaseuttisesti hyväksyttävä suola ja monoamiinioksidaasin inhibiittori käytettäväksi yhden tai useamman huimausoireen hoitamisessa tai ehkäisemisessä kohteessa
JP2016505050A5 (enExample)
WO2016015798A9 (en) Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
JP2018039810A5 (enExample)
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
MX2022012693A (es) Composicion que comprende metilfolato.
JP2019507786A5 (enExample)